Production (Stage)
Kiora Pharmaceuticals, Inc.
KPRX
$3.08
-$0.01-0.32%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 48.08% | -23.74% | -53.64% | -116.51% | 693.02% |
| Total Depreciation and Amortization | 12.64% | 22.54% | -20.67% | 10.49% | 120.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 367.31% | -114.66% | 415.30% | 21.38% | -56.32% |
| Change in Net Operating Assets | -144.25% | -36.23% | 290.90% | -22,051.28% | 98.71% |
| Cash from Operations | -20.06% | -344.80% | 124.65% | -127.40% | 627.83% |
| Capital Expenditure | -- | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 510.65% | 122.79% | 90.93% | -- | -- |
| Cash from Investing | 453.72% | 125.14% | 90.95% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -100.00% | -98.48% | 191,048.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | 100.09% | -140.65% |
| Cash from Financing | -- | -- | -100.00% | -98.36% | 3,234.79% |
| Foreign Exchange rate Adjustments | 113.38% | -221.19% | 790.00% | 113.73% | -141.73% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.85% | -96.72% | 96.20% | -185.70% | 1,078.46% |